{"DataElement":{"publicId":"5583782","version":"1","preferredName":"Dynamic International Prognostic Scoring System Maximum Score Assessment Timepoint Type","preferredDefinition":"A description of when the maximum Dynamic International Prognostic Scoring System score was assessed.","longName":"5582933v1.0:5583741v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5582933","version":"1","preferredName":"Dynamic International Prognostic Scoring System Maximum Score","preferredDefinition":"A time-dependent risk evaluation system for primary myelofibrosis that evaluates disease progression over time. This model includes age older than 65 years, hemoglobin level lower than 10 g/dL, white blood cell count more than 25×10^9/L, peripheral blood blasts equal to or higher than 1%, and constitutional symptoms in order to assign a patient to one of 4 risk categories._The largest possible quantity or degree._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"5611406v1.0:5611407v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5611406","version":"1","preferredName":"Dynamic International Prognostic Scoring System","preferredDefinition":"A system of prognostic categorizations for myelodysplasia syndrome that evaluates disease progression over time based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood.","longName":"C129683","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dynamic International Prognostic Scoring System","conceptCode":"C129683","definition":"A time-dependent risk evaluation system for primary myelofibrosis that evaluates disease progression over time. This model includes age older than 65 years, hemoglobin level lower than 10 g/dL, white blood cell count more than 25x10^9/L, peripheral blood blasts equal to or higher than 1%, and constitutional symptoms in order to assign a patient to one of 4 risk categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E60D06-3308-371A-E053-F662850AAA9C","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ZHANGW","dateCreated":"2016-12-30","modifiedBy":"ONEDATA","dateModified":"2016-12-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5611407","version":"1","preferredName":"Maximum Score","preferredDefinition":"the largest possible quantity or degree.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25564:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maximum","conceptCode":"C25564","definition":"The largest possible quantity or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E60D06-3319-371A-E053-F662850AAA9C","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ZHANGW","dateCreated":"2016-12-30","modifiedBy":"ONEDATA","dateModified":"2016-12-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42870AA5-6A1B-38FC-E053-F662850AA83B","latestVersionIndicator":"Yes","beginDate":"2016-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-30","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5583741","version":"1","preferredName":"Dynamic International Prognostic Scoring System Assessment Timepoint Type","preferredDefinition":"A time-dependent risk evaluation system for primary myelofibrosis that evaluates disease progression over time. This model includes age older than 65 years, hemoglobin level lower than 10 g/dL, white blood cell count more than 25×10^9/L, peripheral blood blasts equal to or higher than 1%, and constitutional symptoms in order to assign a patient to one of 4 risk categories._The final result of a determination of the value, significance, or extent of._A specific point in the time continuum, including those established relative to an event._Something distinguishable as an identifiable class based on common qualities.","longName":"5583741v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Between diagnosis and the preparative regimen","valueDescription":"Post Diagnosis And Prior Preparative Regimen","ValueMeaning":{"publicId":"5583762","version":"1","preferredName":"Post Diagnosis And Prior Preparative Regimen","longName":"5583762","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Earlier in time or order.: The chemotherapy and/or radiation given to blood, marrow or cord blood transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preparative Regimen","conceptCode":"C61155","definition":"The chemotherapy or radiation given prior to blood, marrow, cord blood transplant, or cell infusion to kill diseased cells and make space for the healthy new graft and/or suppress the immune system so rejection does not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4298654A-3D2C-6AF6-E053-F662850A07BA","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4298654A-3D45-6AF6-E053-F662850A07BA","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"ONEDATA","dateModified":"2016-12-01","deletedIndicator":"No"},{"value":"At diagnosis","valueDescription":"At Diagnosis","ValueMeaning":{"publicId":"5583763","version":"1","preferredName":"At Diagnosis","longName":"5583763","preferredDefinition":"Used to indicate position, location, or state.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"At","conceptCode":"C25427","definition":"Used to indicate position, location, or state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4298654A-3D4F-6AF6-E053-F662850A07BA","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4298654A-3D68-6AF6-E053-F662850A07BA","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"ONEDATA","dateModified":"2016-12-01","deletedIndicator":"No"},{"value":"At last evaluation prior to the start of the preparative regimen","valueDescription":"At Last Evaluation Prior Preparative Regimen","ValueMeaning":{"publicId":"5583764","version":"1","preferredName":"At Last Evaluation Prior Preparative Regimen","longName":"5583764","preferredDefinition":"Used to indicate position, location, or state.: Coming after all others in time or space or degree or being the only one remaining.: Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.: Earlier in time or order.: The chemotherapy and/or radiation given to blood, marrow or cord blood transplant patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"At","conceptCode":"C25427","definition":"Used to indicate position, location, or state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Last","conceptCode":"C25551","definition":"Coming after all others in time or space or degree or being the only one remaining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preparative Regimen","conceptCode":"C61155","definition":"The chemotherapy or radiation given prior to blood, marrow, cord blood transplant, or cell infusion to kill diseased cells and make space for the healthy new graft and/or suppress the immune system so rejection does not occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4298654A-3D7B-6AF6-E053-F662850A07BA","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4298654A-3D94-6AF6-E053-F662850A07BA","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"ONEDATA","dateModified":"2016-12-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5583740","version":"1","preferredName":"Dynamic International Prognostic Scoring System Assessment Timepoint Type","preferredDefinition":"A system of prognostic categorizations for myelodysplasia syndrome that evaluates disease progression over time based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood.:The final result of a determination of the value, significance, or extent of.:A specific point in the time continuum, including those established relative to an event.:Something distinguishable as an identifiable class based on common qualities.","longName":"C129683:C25217:C68568:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dynamic International Prognostic Scoring System","conceptCode":"C129683","definition":"A time-dependent risk evaluation system for primary myelofibrosis that evaluates disease progression over time. This model includes age older than 65 years, hemoglobin level lower than 10 g/dL, white blood cell count more than 25x10^9/L, peripheral blood blasts equal to or higher than 1%, and constitutional symptoms in order to assign a patient to one of 4 risk categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4298654A-3BFB-6AF6-E053-F662850A07BA","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"ONEDATA","dateModified":"2016-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4298654A-3C0C-6AF6-E053-F662850A07BA","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"When was the maximum Dynamic","type":"Preferred Question Text","description":"When was the maximum Dynamic International Prognostic Scoring System score assessed?","url":null,"context":"NHLBI"},{"name":"Specify when maximum DIPSS score was documented","type":"Alternate Question Text","description":"Specify when maximum DIPSS score was documented","url":null,"context":"NHLBI"},{"name":"Specify when maximum DIPSS score was documented","type":"Application Standard Question Text","description":"Specify when maximum DIPSS score was documented","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4299F38D-38E3-0935-E053-F662850A07DA","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-01","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}